| ■ 영문 제목 : Global Bacterial Disease Diagnostics Market 2023-2027 | |
![]() | ■ 상품코드 : IRTNTR72443-23 ■ 조사/발행회사 : Technavio ■ 발행일 : 2023년 2월 최신판(2025년 또는 2026년)은 문의주세요. ■ 페이지수 : 약120 ■ 작성언어 : 영문 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (24시간 이내) ■ 조사대상 지역 : 북미, 유럽, 아시아 태평양, 기타 지역 ■ 산업 분야 : 의료 |
| Single User (1명 열람용) | USD2,500 ⇒환산₩3,500,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산₩5,600,000 | 견적의뢰/주문/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| Technavio사는 세계의 세균성 질환 진단 시장 규모가 2022년에서 2027년 사이에 3,766.05백만 달러에 이르며, 예측 기간 동안 연평균 6.28% 감소할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 세균성 질환 진단 시장에 대해 조사 및 분석을 실시하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, Five Force 분석, 제품별 (소모품, 의료 기기) 분석, 최종 용도별 (병원, 실험실) 분석, 고객 현황, 지역별 현황 (북미, 아시아 태평양, 유럽, 기타 지역, 미국, 캐나다, 독일, 영국, 일본) 분석, 성장 요인/과제/동향, 기업 현황, 기업 분석 등의 내용을 게재하고 있습니다. 또한 본 조사 보고서는 Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd. 와 같은 기업 정보를 포함하고 있습니다. ・개요 ・시장 현황 ・시장 규모 예측 ・과거 시장 규모 ・Five Force 분석 ・세계의 세균성 질환 진단 시장 규모 : 제품별 - 소모품의 시장 규모 - 의료 기기의 시장 규모 ・세계의 세균성 질환 진단 시장 규모 : 최종 용도별 - 병원에서 사용되는 세균성 질환 진단의 시장 규모 - 실험실에서 사용되는 세균성 질환 진단의 시장 규모 ・고객 현황 ・지역별 현황 - 북미의 세균성 질환 진단 시장 규모 - 유럽의 세균성 질환 진단 시장 규모 - 아시아 태평양의 의 세균성 질환 진단 시장 규모 - 기타 지역의 세균성 질환 진단 시장 규모 - 미국의 세균성 질환 진단 시장 규모 - 캐나다의 세균성 질환 진단 시장 규모 - 독일의 세균성 질환 진단 시장 규모 - 영국의 세균성 질환 진단 시장 규모 - 일본의 세균성 질환 진단 시장 규모 ・성장 요인/과제/동향 ・기업 현황 ・기업 분석 Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 세균성 질환 진단 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 세균성 질환 진단 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
글로벌 세균 질병 진단 시장에 대한 Technavio의 보고서에 따르면, 이 시장은 2022년부터 2027년까지 37억 6,605만 달러 성장할 것으로 예상되며, 이 기간 동안 연평균 성장률(CAGR)은 6.28%로 둔화될 것으로 보입니다. 이 보고서는 세균 질병 진단 시장에 대한 종합적인 분석, 시장 규모 및 예측, 트렌드, 성장 요인 및 도전 과제, 약 25개의 공급업체에 대한 분석을 제공합니다.
현재 시장 상황, 최신 트렌드 및 성장 요인을 포함한 업데이트된 분석을 제공하며, 이 시장은 세균 질병의 신속 진단에 디지털 헬스 통합, 감염성 질병의 높은 유병률, 인수합병(M&A) 활동의 증가에 의해 주도되고 있습니다.
세균 질병 진단 시장은 제품, 최종 사용자, 지리적 영역으로 구분됩니다. 제품별로는 소모품과 기기로, 최종 사용자별로는 병원과 실험실로 나뉘며, 지리적 영역은 북미, 유럽, 아시아, 기타 지역(ROW)으로 구분됩니다.
이번 연구에서는 휴대용 분석 기기에 대한 수요 증가가 향후 세균 질병 진단 시장 성장의 주요 원인 중 하나로 지목되고 있으며, 파트너십 및 협업 증가와 임상 개발 역시 시장에 상당한 수요를 불러일으킬 것이라고 합니다.
Technavio의 보고서는 세균 질병 진단 시장 크기, 예측, 산업 분석을 포함하여 시장의 다양한 측면을 다루고 있습니다. 또한, Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., GENERI BIOTECH s.r.o., Great Basin Scientific, Hologic Inc., Meridian Bioscience Inc., Perkin Elmer Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, T2 Biosystems Inc., Takara Bio Inc. 등 주요 공급업체에 대한 상세한 분석도 포함되어 있습니다.
이 보고서는 시장 성장에 영향을 미치는 다가오는 트렌드와 도전 과제에 대한 정보도 포함되어 있어, 기업들이 향후 성장 기회를 전략적으로 활용할 수 있도록 돕고자 합니다. 연구는 주요 산업 참여자들로부터의 정보를 포함한 주관적 및 객관적 데이터를 조합하여 수행되었으며, 포괄적인 시장 및 공급업체 환경과 주요 공급업체 분석을 제공합니다.
Technavio는 수익, 가격, 경쟁, 프로모션과 같은 주요 매개변수 분석을 통해 시장의 상세한 그림을 제시하며, 주요 산업 영향력을 식별함으로써 다양한 시장 측면을 제공합니다. 제공되는 데이터는 신뢰할 수 있으며, 광범위한 1차 및 2차 연구의 결과입니다. Technavio의 시장 조사 보고서는 완전한 경쟁 환경과 심층적인 공급업체 선정 방법론 및 분석을 제공하여 정확한 시장 성장을 예측합니다.
■ 보고서 목차• 1 요약 • 3 시장 규모 • 4 과거 시장 규모 o 표 38: 계측기 차트 – 2022-2027년 시장 규모 및 전망 (백만 달러) o 표 47: 병원 – 시장 규모 및 전망 2022-2027(백만 달러) 차트 o 표 51: 검사실 차트 – 2022-2027년 시장 규모 및 전망(백만 달러) • 8 고객 현황 o 표 61: 북미 시장 규모 및 전망 2022-2027년 차트(백만 달러) o 표 65: 유럽 차트 – 2022-2027년 시장 규모 및 전망 (백만 달러) o 표 77: 미국 시장 규모 및 전망 2022-2027 차트(백만 달러) o 표 81: 캐나다 시장 규모 및 전망 2022-2027 차트(백만 달러) o 표 82: 캐나다 시장 규모 및 전망 데이터 표 2022-2027년 (백만 달러) • 12 공급업체 분석 첨부 자료: 표 1: 요약 – 시장 개요 차트 첨부자료 84: 캐나다 전년 대비 성장률 표 2022-2027 (%) 첨부자료 85: 독일 시장 규모 차트 – 3월 시장 규모 및 전망 2022-2027 (백만 달러) 첨부자료 127: 다나허(Danaher Corp.) – 주요 뉴스 o 1.1 Market overview o Exhibit 01: Executive Summary - Chart on Market Overview o Exhibit 02: Executive Summary - Data Table on Market Overview o Exhibit 03: Executive Summary - Chart on Global Market Characteristics o Exhibit 04: Executive Summary - Chart on Market by Geography o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user o Exhibit 07: Executive Summary - Chart on Incremental Growth o Exhibit 08: Executive Summary - Data Table on Incremental Growth o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning • 2 Market Landscape o 2.1 Market ecosystem o Exhibit 10: Parent market o Exhibit 11: Market Characteristics • 3 Market Sizing o 3.1 Market definition o Exhibit 12: Offerings of vendors included in the market definition o 3.2 Market segment analysis o Exhibit 13: Market segments o 3.3 Market size 2022 o 3.4 Market outlook: Forecast for 2022-2027 o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million) o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%) o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) • 4 Historic Market Size o 4.1 Global bacterial disease diagnostics market 2017 - 2021 o Exhibit 18: Historic Market Size - Data Table on Global bacterial disease diagnostics market 2017 - 2021 ($ million) o 4.2 Product Segment Analysis 2017 - 2021 o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million) o 4.3 End-user Segment Analysis 2017 - 2021 o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million) o 4.4 Geography Segment Analysis 2017 - 2021 o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) o 4.5 Country Segment Analysis 2017 - 2021 o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million) • 5 Five Forces Analysis o 5.1 Five forces summary o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027 o 5.2 Bargaining power of buyers o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 o 5.3 Bargaining power of suppliers o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 o 5.4 Threat of new entrants o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027 o 5.5 Threat of substitutes o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027 o 5.6 Threat of rivalry o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027 o 5.7 Market condition o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027 • 6 Market Segmentation by Product o 6.1 Market segments o Exhibit 30: Chart on Product - Market share 2022-2027 (%) o Exhibit 31: Data Table on Product - Market share 2022-2027 (%) o 6.2 Comparison by Product o Exhibit 32: Chart on Comparison by Product o Exhibit 33: Data Table on Comparison by Product o 6.3 Consumables - Market size and forecast 2022-2027 o Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 ($ million) o Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million) o Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%) o Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%) o 6.4 Instruments - Market size and forecast 2022-2027 o Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million) o Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million) o Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%) o Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%) o 6.5 Market opportunity by Product o Exhibit 42: Market opportunity by Product ($ million) • 7 Market Segmentation by End-user o 7.1 Market segments o Exhibit 43: Chart on End-user - Market share 2022-2027 (%) o Exhibit 44: Data Table on End-user - Market share 2022-2027 (%) o 7.2 Comparison by End-user o Exhibit 45: Chart on Comparison by End-user o Exhibit 46: Data Table on Comparison by End-user o 7.3 Hospitals - Market size and forecast 2022-2027 o Exhibit 47: Chart on Hospitals - Market size and forecast 2022-2027 ($ million) o Exhibit 48: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million) o Exhibit 49: Chart on Hospitals - Year-over-year growth 2022-2027 (%) o Exhibit 50: Data Table on Hospitals - Year-over-year growth 2022-2027 (%) o 7.4 Labs - Market size and forecast 2022-2027 o Exhibit 51: Chart on Labs - Market size and forecast 2022-2027 ($ million) o Exhibit 52: Data Table on Labs - Market size and forecast 2022-2027 ($ million) o Exhibit 53: Chart on Labs - Year-over-year growth 2022-2027 (%) o Exhibit 54: Data Table on Labs - Year-over-year growth 2022-2027 (%) o 7.5 Market opportunity by End-user o Exhibit 55: Market opportunity by End-user ($ million) • 8 Customer Landscape o 8.1 Customer landscape overview o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • 9 Geographic Landscape o 9.1 Geographic segmentation o Exhibit 57: Chart on Market share by geography 2022-2027 (%) o Exhibit 58: Data Table on Market share by geography 2022-2027 (%) o 9.2 Geographic comparison o Exhibit 59: Chart on Geographic comparison o Exhibit 60: Data Table on Geographic comparison o 9.3 North America - Market size and forecast 2022-2027 o Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million) o Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%) o Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%) o 9.4 Europe - Market size and forecast 2022-2027 o Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million) o Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%) o Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%) o 9.5 Asia - Market size and forecast 2022-2027 o Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million) o Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million) o Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%) o Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%) o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 o Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) o Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) o Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) o Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) o 9.7 US - Market size and forecast 2022-2027 o Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million) o Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million) o Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%) o Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%) o 9.8 Canada - Market size and forecast 2022-2027 o Exhibit 81: Chart on Canada - Market size and forecast 2022-2027 ($ million) o Exhibit 82: Data Table on Canada - Market size and forecast 2022-2027 ($ million) o Exhibit 83: Chart on Canada - Year-over-year growth 2022-2027 (%) o Exhibit 84: Data Table on Canada - Year-over-year growth 2022-2027 (%) o 9.9 Germany - Market size and forecast 2022-2027 o Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million) o Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%) o Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%) o 9.10 UK - Market size and forecast 2022-2027 o Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million) o Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%) o Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%) o 9.11 Japan - Market size and forecast 2022-2027 o Exhibit 93: Chart on Japan - Market size and forecast 2022-2027 ($ million) o Exhibit 94: Data Table on Japan - Market size and forecast 2022-2027 ($ million) o Exhibit 95: Chart on Japan - Year-over-year growth 2022-2027 (%) o Exhibit 96: Data Table on Japan - Year-over-year growth 2022-2027 (%) o 9.12 Market opportunity by geography o Exhibit 97: Market opportunity by geography ($ million) • 10 Drivers, Challenges, and Trends o 10.1 Market drivers o 10.2 Market challenges o 10.3 Impact of drivers and challenges o Exhibit 98: Impact of drivers and challenges in 2022 and 2027 o 10.4 Market trends • 11 Vendor Landscape o 11.1 Overview o 11.2 Vendor landscape o Exhibit 99: Overview on Criticality of inputs and Factors of differentiation o 11.3 Landscape disruption o Exhibit 100: Overview on factors of disruption o 11.4 Industry risks o Exhibit 101: Impact of key risks on business • 12 Vendor Analysis o 12.1 Vendors covered o Exhibit 102: Vendors covered o 12.2 Market positioning of vendors o Exhibit 103: Matrix on vendor position and classification o 12.3 Abbott Laboratories o Exhibit 104: Abbott Laboratories - Overview o Exhibit 105: Abbott Laboratories - Business segments o Exhibit 106: Abbott Laboratories - Key news o Exhibit 107: Abbott Laboratories - Key offerings o Exhibit 108: Abbott Laboratories - Segment focus o 12.4 Accelerate Diagnostics Inc. o Exhibit 109: Accelerate Diagnostics Inc. - Overview o Exhibit 110: Accelerate Diagnostics Inc. - Product / Service o Exhibit 111: Accelerate Diagnostics Inc. - Key offerings o 12.5 Becton Dickinson and Co. o Exhibit 112: Becton Dickinson and Co. - Overview o Exhibit 113: Becton Dickinson and Co. - Business segments o Exhibit 114: Becton Dickinson and Co. - Key news o Exhibit 115: Becton Dickinson and Co. - Key offerings o Exhibit 116: Becton Dickinson and Co. - Segment focus o 12.6 Bio Rad Laboratories Inc. o Exhibit 117: Bio Rad Laboratories Inc. - Overview o Exhibit 118: Bio Rad Laboratories Inc. - Business segments o Exhibit 119: Bio Rad Laboratories Inc. - Key news o Exhibit 120: Bio Rad Laboratories Inc. - Key offerings o Exhibit 121: Bio Rad Laboratories Inc. - Segment focus o 12.7 bioMerieux SA o Exhibit 122: bioMerieux SA - Overview o Exhibit 123: bioMerieux SA - Product / Service o Exhibit 124: bioMerieux SA - Key offerings o 12.8 Danaher Corp. o Exhibit 125: Danaher Corp. - Overview o Exhibit 126: Danaher Corp. - Business segments o Exhibit 127: Danaher Corp. - Key news o Exhibit 128: Danaher Corp. - Key offerings o Exhibit 129: Danaher Corp. - Segment focus o 12.9 DiaSorin SpA o Exhibit 130: DiaSorin SpA - Overview o Exhibit 131: DiaSorin SpA - Business segments o Exhibit 132: DiaSorin SpA - Key news o Exhibit 133: DiaSorin SpA - Key offerings o Exhibit 134: DiaSorin SpA - Segment focus o 12.10 EKF Diagnostics Holdings Plc o Exhibit 135: EKF Diagnostics Holdings Plc - Overview o Exhibit 136: EKF Diagnostics Holdings Plc - Business segments o Exhibit 137: EKF Diagnostics Holdings Plc - Key offerings o Exhibit 138: EKF Diagnostics Holdings Plc - Segment focus o 12.11 F. Hoffmann La Roche Ltd. o Exhibit 139: F. Hoffmann La Roche Ltd. - Overview o Exhibit 140: F. Hoffmann La Roche Ltd. - Business segments o Exhibit 141: F. Hoffmann La Roche Ltd. - Key news o Exhibit 142: F. Hoffmann La Roche Ltd. - Key offerings o Exhibit 143: F. Hoffmann La Roche Ltd. - Segment focus o 12.12 Hologic Inc. o Exhibit 144: Hologic Inc. - Overview o Exhibit 145: Hologic Inc. - Business segments o Exhibit 146: Hologic Inc. - Key news o Exhibit 147: Hologic Inc. - Key offerings o Exhibit 148: Hologic Inc. - Segment focus o 12.13 Perkin Elmer Inc. o Exhibit 149: Perkin Elmer Inc. - Overview o Exhibit 150: Perkin Elmer Inc. - Business segments o Exhibit 151: Perkin Elmer Inc. - Key news o Exhibit 152: Perkin Elmer Inc. - Key offerings o Exhibit 153: Perkin Elmer Inc. - Segment focus o 12.14 QIAGEN NV o Exhibit 154: QIAGEN NV - Overview o Exhibit 155: QIAGEN NV - Product / Service o Exhibit 156: QIAGEN NV - Key news o Exhibit 157: QIAGEN NV - Key offerings o 12.15 Quest Diagnostics Inc. o Exhibit 158: Quest Diagnostics Inc. - Overview o Exhibit 159: Quest Diagnostics Inc. - Business segments o Exhibit 160: Quest Diagnostics Inc. - Key offerings o Exhibit 161: Quest Diagnostics Inc. - Segment focus o 12.16 Siemens AG o Exhibit 162: Siemens AG - Overview o Exhibit 163: Siemens AG - Business segments o Exhibit 164: Siemens AG - Key news o Exhibit 165: Siemens AG - Key offerings o Exhibit 166: Siemens AG - Segment focus o 12.17 Takara Bio Inc. o Exhibit 167: Takara Bio Inc. - Overview o Exhibit 168: Takara Bio Inc. - Business segments o Exhibit 169: Takara Bio Inc. - Key offerings o Exhibit 170: Takara Bio Inc. - Segment focus • 13 Appendix o 13.1 Scope of the report o 13.2 Inclusions and exclusions checklist o Exhibit 171: Inclusions checklist o Exhibit 172: Exclusions checklist o 13.3 Currency conversion rates for US$ o Exhibit 173: Currency conversion rates for US$ o 13.4 Research methodology o Exhibit 174: Research methodology o Exhibit 175: Validation techniques employed for market sizing o Exhibit 176: Information sources o 13.5 List of abbreviations o Exhibit 177: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market by Geography Exhibits5: Executive Summary - Chart on Market Segmentation by Product Exhibits6: Executive Summary - Chart on Market Segmentation by End-user Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million) Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million) Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%) Exhibits18: Historic Market Size - Data Table on Global bacterial disease diagnostics market 2017 - 2021 ($ million) Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million) Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million) Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million) Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million) Exhibits23: Five forces analysis - Comparison between 2022 and 2027 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027 Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027 Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027 Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027 Exhibits29: Chart on Market condition - Five forces 2022 and 2027 Exhibits30: Chart on Product - Market share 2022-2027 (%) Exhibits31: Data Table on Product - Market share 2022-2027 (%) Exhibits32: Chart on Comparison by Product Exhibits33: Data Table on Comparison by Product Exhibits34: Chart on Consumables - Market size and forecast 2022-2027 ($ million) Exhibits35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million) Exhibits36: Chart on Consumables - Year-over-year growth 2022-2027 (%) Exhibits37: Data Table on Consumables - Year-over-year growth 2022-2027 (%) Exhibits38: Chart on Instruments - Market size and forecast 2022-2027 ($ million) Exhibits39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million) Exhibits40: Chart on Instruments - Year-over-year growth 2022-2027 (%) Exhibits41: Data Table on Instruments - Year-over-year growth 2022-2027 (%) Exhibits42: Market opportunity by Product ($ million) Exhibits43: Chart on End-user - Market share 2022-2027 (%) Exhibits44: Data Table on End-user - Market share 2022-2027 (%) Exhibits45: Chart on Comparison by End-user Exhibits46: Data Table on Comparison by End-user Exhibits47: Chart on Hospitals - Market size and forecast 2022-2027 ($ million) Exhibits48: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million) Exhibits49: Chart on Hospitals - Year-over-year growth 2022-2027 (%) Exhibits50: Data Table on Hospitals - Year-over-year growth 2022-2027 (%) Exhibits51: Chart on Labs - Market size and forecast 2022-2027 ($ million) Exhibits52: Data Table on Labs - Market size and forecast 2022-2027 ($ million) Exhibits53: Chart on Labs - Year-over-year growth 2022-2027 (%) Exhibits54: Data Table on Labs - Year-over-year growth 2022-2027 (%) Exhibits55: Market opportunity by End-user ($ million) Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits57: Chart on Market share by geography 2022-2027 (%) Exhibits58: Data Table on Market share by geography 2022-2027 (%) Exhibits59: Chart on Geographic comparison Exhibits60: Data Table on Geographic comparison Exhibits61: Chart on North America - Market size and forecast 2022-2027 ($ million) Exhibits62: Data Table on North America - Market size and forecast 2022-2027 ($ million) Exhibits63: Chart on North America - Year-over-year growth 2022-2027 (%) Exhibits64: Data Table on North America - Year-over-year growth 2022-2027 (%) Exhibits65: Chart on Europe - Market size and forecast 2022-2027 ($ million) Exhibits66: Data Table on Europe - Market size and forecast 2022-2027 ($ million) Exhibits67: Chart on Europe - Year-over-year growth 2022-2027 (%) Exhibits68: Data Table on Europe - Year-over-year growth 2022-2027 (%) Exhibits69: Chart on Asia - Market size and forecast 2022-2027 ($ million) Exhibits70: Data Table on Asia - Market size and forecast 2022-2027 ($ million) Exhibits71: Chart on Asia - Year-over-year growth 2022-2027 (%) Exhibits72: Data Table on Asia - Year-over-year growth 2022-2027 (%) Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million) Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%) Exhibits77: Chart on US - Market size and forecast 2022-2027 ($ million) Exhibits78: Data Table on US - Market size and forecast 2022-2027 ($ million) Exhibits79: Chart on US - Year-over-year growth 2022-2027 (%) Exhibits80: Data Table on US - Year-over-year growth 2022-2027 (%) Exhibits81: Chart on Canada - Market size and forecast 2022-2027 ($ million) Exhibits82: Data Table on Canada - Market size and forecast 2022-2027 ($ million) Exhibits83: Chart on Canada - Year-over-year growth 2022-2027 (%) Exhibits84: Data Table on Canada - Year-over-year growth 2022-2027 (%) Exhibits85: Chart on Germany - Market size and forecast 2022-2027 ($ million) Exhibits86: Data Table on Germany - Market size and forecast 2022-2027 ($ million) Exhibits87: Chart on Germany - Year-over-year growth 2022-2027 (%) Exhibits88: Data Table on Germany - Year-over-year growth 2022-2027 (%) Exhibits89: Chart on UK - Market size and forecast 2022-2027 ($ million) Exhibits90: Data Table on UK - Market size and forecast 2022-2027 ($ million) Exhibits91: Chart on UK - Year-over-year growth 2022-2027 (%) Exhibits92: Data Table on UK - Year-over-year growth 2022-2027 (%) Exhibits93: Chart on Japan - Market size and forecast 2022-2027 ($ million) Exhibits94: Data Table on Japan - Market size and forecast 2022-2027 ($ million) Exhibits95: Chart on Japan - Year-over-year growth 2022-2027 (%) Exhibits96: Data Table on Japan - Year-over-year growth 2022-2027 (%) Exhibits97: Market opportunity by geography ($ million) Exhibits98: Impact of drivers and challenges in 2022 and 2027 Exhibits99: Overview on Criticality of inputs and Factors of differentiation Exhibits100: Overview on factors of disruption Exhibits101: Impact of key risks on business Exhibits102: Vendors covered Exhibits103: Matrix on vendor position and classification Exhibits104: Abbott Laboratories - Overview Exhibits105: Abbott Laboratories - Business segments Exhibits106: Abbott Laboratories - Key news Exhibits107: Abbott Laboratories - Key offerings Exhibits108: Abbott Laboratories - Segment focus Exhibits109: Accelerate Diagnostics Inc. - Overview Exhibits110: Accelerate Diagnostics Inc. - Product / Service Exhibits111: Accelerate Diagnostics Inc. - Key offerings Exhibits112: Becton Dickinson and Co. - Overview Exhibits113: Becton Dickinson and Co. - Business segments Exhibits114: Becton Dickinson and Co. - Key news Exhibits115: Becton Dickinson and Co. - Key offerings Exhibits116: Becton Dickinson and Co. - Segment focus Exhibits117: Bio Rad Laboratories Inc. - Overview Exhibits118: Bio Rad Laboratories Inc. - Business segments Exhibits119: Bio Rad Laboratories Inc. - Key news Exhibits120: Bio Rad Laboratories Inc. - Key offerings Exhibits121: Bio Rad Laboratories Inc. - Segment focus Exhibits122: bioMerieux SA - Overview Exhibits123: bioMerieux SA - Product / Service Exhibits124: bioMerieux SA - Key offerings Exhibits125: Danaher Corp. - Overview Exhibits126: Danaher Corp. - Business segments Exhibits127: Danaher Corp. - Key news Exhibits128: Danaher Corp. - Key offerings Exhibits129: Danaher Corp. - Segment focus Exhibits130: DiaSorin SpA - Overview Exhibits131: DiaSorin SpA - Business segments Exhibits132: DiaSorin SpA - Key news Exhibits133: DiaSorin SpA - Key offerings Exhibits134: DiaSorin SpA - Segment focus Exhibits135: EKF Diagnostics Holdings Plc - Overview Exhibits136: EKF Diagnostics Holdings Plc - Business segments Exhibits137: EKF Diagnostics Holdings Plc - Key offerings Exhibits138: EKF Diagnostics Holdings Plc - Segment focus Exhibits139: F. Hoffmann La Roche Ltd. - Overview Exhibits140: F. Hoffmann La Roche Ltd. - Business segments Exhibits141: F. Hoffmann La Roche Ltd. - Key news Exhibits142: F. Hoffmann La Roche Ltd. - Key offerings Exhibits143: F. Hoffmann La Roche Ltd. - Segment focus Exhibits144: Hologic Inc. - Overview Exhibits145: Hologic Inc. - Business segments Exhibits146: Hologic Inc. - Key news Exhibits147: Hologic Inc. - Key offerings Exhibits148: Hologic Inc. - Segment focus Exhibits149: Perkin Elmer Inc. - Overview Exhibits150: Perkin Elmer Inc. - Business segments Exhibits151: Perkin Elmer Inc. - Key news Exhibits152: Perkin Elmer Inc. - Key offerings Exhibits153: Perkin Elmer Inc. - Segment focus Exhibits154: QIAGEN NV - Overview Exhibits155: QIAGEN NV - Product / Service Exhibits156: QIAGEN NV - Key news Exhibits157: QIAGEN NV - Key offerings Exhibits158: Quest Diagnostics Inc. - Overview Exhibits159: Quest Diagnostics Inc. - Business segments Exhibits160: Quest Diagnostics Inc. - Key offerings Exhibits161: Quest Diagnostics Inc. - Segment focus Exhibits162: Siemens AG - Overview Exhibits163: Siemens AG - Business segments Exhibits164: Siemens AG - Key news Exhibits165: Siemens AG - Key offerings Exhibits166: Siemens AG - Segment focus Exhibits167: Takara Bio Inc. - Overview Exhibits168: Takara Bio Inc. - Business segments Exhibits169: Takara Bio Inc. - Key offerings Exhibits170: Takara Bio Inc. - Segment focus Exhibits171: Inclusions checklist Exhibits172: Exclusions checklist Exhibits173: Currency conversion rates for US$ Exhibits174: Research methodology Exhibits175: Validation techniques employed for market sizing Exhibits176: Information sources Exhibits177: List of abbreviations |
| ※참고 정보 세균성 질환 진단은 세균에 의해 발생하는 다양한 질병을 정확하게 식별하고 진단하기 위한 과정을 의미한다. 이러한 질병들은 감염된 환자의 건강에 심각한 영향을 미칠 수 있으며, 조기 진단과 적절한 치료가 필요하다. 세균성 질환의 진단은 환자의 증상, 병력, 그리고 다양한 진단 검사를 포함하여 이루어진다. 세균성 질환은 세균의 종류와 감염된 부위에 따라 다양하게 분류된다. 예를 들어, 호흡기 질환, 장 감염, 피부 감염, 비뇨기계 감염, 패혈증 등 여러 가지 형태가 있으며, 각각의 질병은 특정한 세균에 의해 유발된다. 대표적인 세균성 질환으로는 폐렴, 결핵, 장티푸스, 성병 등이 있다. 세균성 질환의 진단에는 여러 가지 방법이 사용된다. 가장 일반적인 방법 중 하나는 환자의 체액(혈액, 소변, 배양액 등)을 채취하여 실험실에서 분석하는 것이며, 특정한 세균을 배양하고 확인하는 방법이 포함된다. 이러한 과정은 병원체의 수를 확인하고, 어떤 종류의 세균이 감염을 일으켰는지를 파악하는 데 도움이 된다. 또한 PCR(중합효소 연쇄 반응)을 통해 미생물의 유전물질을 증폭시켜 특정 세균을 더욱 빨리 검출할 수 있는 방법도 자주 사용된다. 또한 항생제 감수성 검사도 중요한 진단 절차 중 하나이다. 이는 특정 세균이 어떤 항생제에 대해 저항력을 가지는지를 확인하여, 효과적인 치료법을 선택하는 데 중요한 정보를 제공한다. 진단 결과에 따라 의사는 적절한 치료를 신속하게 시작할 수 있다. 세균성 질환 진단의 용도는 매우 다양하다. 특히, 급성 감염의 조기 발견과 적절한 치료를 통해 환자의 생명을 구할 수 있다. 또한, 병원에서 발생할 수 있는 세균 감염의 확산을 예방하고, 전염 원인을 파악하여 공중 보건 문제가 될 수 있는 상황을 미연에 방지하는 데에도 필수적이다. 세균성 질환 진단에 필요한 기술들은 날로 발전하고 있다. 기존의 배양 및 화학적 방법에서 최근에는 분자생물학적 방법까지 도입되어 진단의 정확성과 속도가 크게 향상되었다. 예를 들어, 고속 염기서열 분석(NGS) 기술을 활용하면 여러 세균의 DNA를 동시에 분석할 수 있어, 복합 감염 상황에서도 유용하게 사용된다. 또한, 진단장비의 자동화가 진행됨에 따라 의료진의 업무 부담이 줄어들고 진단의 신뢰도가 높아졌다. 결론적으로, 세균성 질환 진단은 질병의 예방과 치료에 중요한 역할을 하며, 다양한 기술과 방법을 통해 지속적으로 발전하고 있다. 이러한 진단 기술은 인류의 건강을 지키는 데 필수적인 요소로 자리잡고 있으며, 앞으로도 더욱 정교하고 신속한 진단 방법들이 개발될 것으로 기대된다. |
| ※본 조사보고서 [세계의 세균성 질환 진단 시장 (2023년~2027년)] (코드 : IRTNTR72443-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 세균성 질환 진단 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |

